Clinical and genetic drivers of oligo-metastatic disease in colon cancer
Open Access
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Tumor mutational burden in colorectal cancer: Implications for treatmentCritical Reviews in Oncology/Hematology, 2024
- BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancerNeoplasia, 2023
- Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists GuidelinesThe Journal of Molecular Diagnostics, 2022
- UALCAN: An update to the integrated cancer data analysis platformNeoplasia, 2022
- Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus documentRadiotherapy and Oncology, 2020
- Intracellular and extracellular TGF-β signaling in cancer: some recent topicsFrontiers of Medicine, 2018
- Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosisClinical and Translational Oncology, 2018
- Oligo-recurrence and Sync-oligometastasesJournal of Thoracic Oncology, 2018
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Modeling Growth Kinetics and Statistical Distribution of OligometastasesSeminars in Radiation Oncology, 2006